Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Prime Therapeutics tells Sunnyside trustees specialty drugs and neoplastics drove pharmacy costs; offers adherence and app-based savings
Summary
Prime Therapeutics reported roughly 1,500 members with plan-paid pharmacy costs around $1.9 million year‑to‑date, specialty spend near $788,000 and payer‑matrix savings of about $291,000; recommended adherence programs, PrimeCentral app and a hybrid payer‑matrix add‑on.
Prime Therapeutics presented the trust’s pharmacy review, highlighting specialty-drug concentrations and several operational savings opportunities.
Kelly Shane, account executive at Prime Therapeutics, said the membership is about 1,500 and that plan-paid pharmacy dollars were roughly $1.9 million year‑to‑date, producing a PMPM around…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
